Therapeutic potential of resveratrol in Alzheimer's disease

BMC Neurosci. 2008 Dec 3;9 Suppl 2(Suppl 2):S6. doi: 10.1186/1471-2202-9-S2-S6.

Abstract

Several epidemiological studies indicate that moderate consumption of red wine is associated with a lower incidence of dementia and Alzheimer's disease. Red wine is enriched in antioxidant polyphenols with potential neuroprotective activities. Despite scepticism concerning the bioavailability of these polyphenols, in vivo data have clearly demonstrated the neuroprotective properties of the naturally occurring polyphenol resveratrol in rodent models for stress and diseases. Furthermore, recent work in cell cultures and animal models has shed light on the molecular mechanisms potentially involved in the beneficial effects of resveratrol intake against the neurodegenerative process in Alzheimer's disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / pathology
  • Animals
  • Antioxidants / chemistry
  • Antioxidants / therapeutic use*
  • Dementia / drug therapy
  • Dementia / pathology
  • Flavonoids / chemistry
  • Flavonoids / therapeutic use
  • Humans
  • Nerve Degeneration / drug therapy
  • Nerve Degeneration / pathology
  • Phenols / chemistry
  • Phenols / therapeutic use
  • Polyphenols
  • Resveratrol
  • Stilbenes / chemistry
  • Stilbenes / therapeutic use*
  • Wine

Substances

  • Antioxidants
  • Flavonoids
  • Phenols
  • Polyphenols
  • Stilbenes
  • Resveratrol